A route to new cancer therapies: the FA pathway is essential in BRCA1- or BRCA2-deficient cells
Crossref DOI link: https://doi.org/10.1038/nsmb.3276
Published Online: 2016-08-03
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lachaud, Christophe
Rouse, John
Text and Data Mining valid from 2016-08-01
Article History
First Online: 3 August 2016
Competing interests
: The authors declare no competing financial interests.